Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Lymph-circulating tumor cells show distinct properties to blood-circulating tumor cells and are efficient metastatic precursors.

Mohammed SI, Torres-Luquis O, Walls E, Lloyd F.

Mol Oncol. 2019 Jun;13(6):1400-1418. doi: 10.1002/1878-0261.12494. Epub 2019 May 23.

2.

Magnetic Focus Lateral Flow Sensor for Detection of Cervical Cancer Biomarkers.

Ren W, Mohammed SI, Wereley S, Irudayaraj J.

Anal Chem. 2019 Feb 19;91(4):2876-2884. doi: 10.1021/acs.analchem.8b04848. Epub 2019 Jan 29.

PMID:
30632735
3.

LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women.

Torres-Luquis O, Madden K, N'dri NM, Berg R, Olopade OF, Ngwa W, Abuidris D, Mittal S, Lyn-Cook B, Mohammed SI.

Breast Cancer (Dove Med Press). 2018 Dec 20;11:1-12. doi: 10.2147/BCTT.S185960. eCollection 2019.

4.

Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy.

Sayedahmed EE, Kumari R, Shukla S, Hassan AO, Mohammed SI, York IA, Gangappa S, Sambhara S, Mittal SK.

Vaccine. 2018 Oct 29;36(45):6744-6751. doi: 10.1016/j.vaccine.2018.09.031. Epub 2018 Sep 25.

5.

Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences.

Tayyari F, Gowda GAN, Olopade OF, Berg R, Yang HH, Lee MP, Ngwa WF, Mittal SK, Raftery D, Mohammed SI.

Oncotarget. 2018 Feb 7;9(14):11677-11690. doi: 10.18632/oncotarget.24433. eCollection 2018 Feb 20.

6.

Significance of Using SYPRO Ruby against CBB R-250 for Visualizing Haematoxylin Stained Proteins in Gels.

Hussain NF, Mohammed SI.

J Oncol Res Ther. 2018;4(1). pii: 141. Epub 2018 Feb 20.

7.

Proteomics Profiling of Pancreatic Cancer and Pancreatitis for Biomarkers Discovery.

Sanh N, Fadul H, Hussein N, Lyn-Cook BD, Hammons G, Ramos-Cardona XE, Mohamed K, Mohammed SI.

J Cell Sci Ther. 2018;9(4). pii: 287. doi: 10.4172/2157-7013.1000287. Epub 2018 Nov 28.

8.

Evaluation of Larvicidal Activity of Essential Oil from Leaves of Coccinia grandis against Three Mosquito Species.

Mohammed SI, Vishwakarma KS, Maheshwari VL.

J Arthropod Borne Dis. 2017 May 27;11(2):226-235. eCollection 2017 Jun.

9.

Experimental Validation of Antidiabetic Potential of Cayratia trifolia (L.) Domin: An Indigenous Medicinal Plant.

Mohammed SI, Salunkhe NS, Vishwakarma KS, Maheshwari VL.

Indian J Clin Biochem. 2017 Jun;32(2):153-162. doi: 10.1007/s12291-016-0598-1. Epub 2016 Aug 3.

10.

Incidence and survival rates of ovarian cancer in low-income women in Sudan.

Abuidris DO, Weng HY, Elhaj AM, Eltayeb EA, Elsanousi M, Ibnoof RS, Mohammed SI.

Mol Clin Oncol. 2016 Dec;5(6):823-828. doi: 10.3892/mco.2016.1068. Epub 2016 Oct 31.

11.

Changing global policy to deliver safe, equitable, and affordable care for women's cancers.

Ginsburg O, Badwe R, Boyle P, Derricks G, Dare A, Evans T, Eniu A, Jimenez J, Kutluk T, Lopes G, Mohammed SI, Qiao YL, Rashid SF, Summers D, Sarfati D, Temmerman M, Trimble EL, Padela AI, Aggarwal A, Sullivan R.

Lancet. 2017 Feb 25;389(10071):871-880. doi: 10.1016/S0140-6736(16)31393-9. Epub 2016 Nov 1. Review.

PMID:
27814964
12.

Risk factors for occurrence and recurrence of diabetic foot ulcers among Iraqi diabetic patients.

Mohammed SI, Mikhael EM, Ahmed FT, Al-Tukmagi HF, Jasim AL.

Diabet Foot Ankle. 2016 Mar 15;7:29605. doi: 10.3402/dfa.v7.29605. eCollection 2016.

13.

Point-of-care test for cervical cancer in LMICs.

Mohammed SI, Ren W, Flowers L, Rajwa B, Chibwesha CJ, Parham GP, Irudayaraj JM.

Oncotarget. 2016 Apr 5;7(14):18787-97. doi: 10.18632/oncotarget.7709.

14.

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AME, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HPV, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HMC, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M.

Semin Cancer Biol. 2015 Dec;35 Suppl:S276-S304. doi: 10.1016/j.semcancer.2015.09.007. Review.

15.

Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?

Burrai GP, Tanca A, De Miglio MR, Abbondio M, Pisanu S, Polinas M, Pirino S, Mohammed SI, Uzzau S, Addis MF, Antuofermo E.

Tumour Biol. 2015 Nov;36(11):9083-91. doi: 10.1007/s13277-015-3661-2. Epub 2015 Jun 19.

PMID:
26088453
16.

A multi-targeted approach to suppress tumor-promoting inflammation.

Samadi AK, Bilsland A, Georgakilas AG, Amedei A, Amin A, Bishayee A, Azmi AS, Lokeshwar BL, Grue B, Panis C, Boosani CS, Poudyal D, Stafforini DM, Bhakta D, Niccolai E, Guha G, Vasantha Rupasinghe HP, Fujii H, Honoki K, Mehta K, Aquilano K, Lowe L, Hofseth LJ, Ricciardiello L, Ciriolo MR, Singh N, Whelan RL, Chaturvedi R, Ashraf SS, Shantha Kumara HMC, Nowsheen S, Mohammed SI, Keith WN, Helferich WG, Yang X.

Semin Cancer Biol. 2015 Dec;35 Suppl:S151-S184. doi: 10.1016/j.semcancer.2015.03.006. Epub 2015 May 5. Review.

17.

Broad targeting of resistance to apoptosis in cancer.

Mohammad RM, Muqbil I, Lowe L, Yedjou C, Hsu HY, Lin LT, Siegelin MD, Fimognari C, Kumar NB, Dou QP, Yang H, Samadi AK, Russo GL, Spagnuolo C, Ray SK, Chakrabarti M, Morre JD, Coley HM, Honoki K, Fujii H, Georgakilas AG, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich WG, Yang X, Boosani CS, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Keith WN, Bilsland A, Halicka D, Nowsheen S, Azmi AS.

Semin Cancer Biol. 2015 Dec;35 Suppl:S78-S103. doi: 10.1016/j.semcancer.2015.03.001. Epub 2015 Apr 28. Review.

18.

Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, Sharma D, Saxena NK, Singh N, Vlachostergios PJ, Guo S, Honoki K, Fujii H, Georgakilas AG, Bilsland A, Amedei A, Niccolai E, Amin A, Ashraf SS, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Keith WN, Nowsheen S.

Semin Cancer Biol. 2015 Dec;35 Suppl:S25-S54. doi: 10.1016/j.semcancer.2015.02.006. Epub 2015 Apr 17. Review.

19.

Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.

Ferguson LR, Chen H, Collins AR, Connell M, Damia G, Dasgupta S, Malhotra M, Meeker AK, Amedei A, Amin A, Ashraf SS, Aquilano K, Azmi AS, Bhakta D, Bilsland A, Boosani CS, Chen S, Ciriolo MR, Fujii H, Guha G, Halicka D, Helferich WG, Keith WN, Mohammed SI, Niccolai E, Yang X, Honoki K, Parslow VR, Prakash S, Rezazadeh S, Shackelford RE, Sidransky D, Tran PT, Yang ES, Maxwell CA.

Semin Cancer Biol. 2015 Dec;35 Suppl:S5-S24. doi: 10.1016/j.semcancer.2015.03.005. Epub 2015 Apr 11. Review.

20.

Therapeutic targeting of replicative immortality.

Yaswen P, MacKenzie KL, Keith WN, Hentosh P, Rodier F, Zhu J, Firestone GL, Matheu A, Carnero A, Bilsland A, Sundin T, Honoki K, Fujii H, Georgakilas AG, Amedei A, Amin A, Helferich B, Boosani CS, Guha G, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Niccolai E, Aquilano K, Ashraf SS, Nowsheen S, Yang X.

Semin Cancer Biol. 2015 Dec;35 Suppl:S104-S128. doi: 10.1016/j.semcancer.2015.03.007. Epub 2015 Apr 11. Review.

21.

Cancer prevention and therapy through the modulation of the tumor microenvironment.

Casey SC, Amedei A, Aquilano K, Azmi AS, Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR, Crawford S, Fujii H, Georgakilas AG, Guha G, Halicka D, Helferich WG, Heneberg P, Honoki K, Keith WN, Kerkar SP, Mohammed SI, Niccolai E, Nowsheen S, Vasantha Rupasinghe HP, Samadi A, Singh N, Talib WH, Venkateswaran V, Whelan RL, Yang X, Felsher DW.

Semin Cancer Biol. 2015 Dec;35 Suppl:S199-S223. doi: 10.1016/j.semcancer.2015.02.007. Epub 2015 Apr 10. Review.

22.

Immune evasion in cancer: Mechanistic basis and therapeutic strategies.

Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, Lichtor T, Decker WK, Whelan RL, Kumara HMCS, Signori E, Honoki K, Georgakilas AG, Amin A, Helferich WG, Boosani CS, Guha G, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Keith WN, Bilsland A, Bhakta D, Halicka D, Fujii H, Aquilano K, Ashraf SS, Nowsheen S, Yang X, Choi BK, Kwon BS.

Semin Cancer Biol. 2015 Dec;35 Suppl:S185-S198. doi: 10.1016/j.semcancer.2015.03.004. Epub 2015 Mar 25. Review.

23.

Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

Amin ARMR, Karpowicz PA, Carey TE, Arbiser J, Nahta R, Chen ZG, Dong JT, Kucuk O, Khan GN, Huang GS, Mi S, Lee HY, Reichrath J, Honoki K, Georgakilas AG, Amedei A, Amin A, Helferich B, Boosani CS, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Keith WN, Bhakta D, Halicka D, Niccolai E, Fujii H, Aquilano K, Ashraf SS, Nowsheen S, Yang X, Bilsland A, Shin DM.

Semin Cancer Biol. 2015 Dec;35 Suppl:S55-S77. doi: 10.1016/j.semcancer.2015.02.005. Epub 2015 Mar 6. Review.

24.

Part I: cancer in Sudan—burden, distribution, and trends breast, gynecological, and prostate cancers.

Elamin A, Ibrahim ME, Abuidris D, Mohamed KE, Mohammed SI.

Cancer Med. 2015 Mar;4(3):447-56. doi: 10.1002/cam4.378. Epub 2015 Jan 30. Review.

25.

Broad targeting of angiogenesis for cancer prevention and therapy.

Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D, Chen YC, Honoki K, Fujii H, Georgakilas AG, Nowsheen S, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich B, Yang X, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Halicka D, Mohammed SI, Azmi AS, Bilsland A, Keith WN, Jensen LD.

Semin Cancer Biol. 2015 Dec;35 Suppl:S224-S243. doi: 10.1016/j.semcancer.2015.01.001. Epub 2015 Jan 16. Review.

26.

Screening for AZFc partial deletions in Dravidian men with nonobstructive azoospermia and oligozoospermia.

Vijesh VV, Nambiar V, Mohammed SI, Sukumaran S, Suganthi R.

Genet Test Mol Biomarkers. 2015 Mar;19(3):150-5. doi: 10.1089/gtmb.2014.0251. Epub 2015 Jan 16.

27.

Sorting reality from what we think we know about breast cancer in Africa.

Mohammed SI, Harford JB.

PLoS Med. 2014 Sep 9;11(9):e1001721. doi: 10.1371/journal.pmed.1001721. eCollection 2014 Sep. Review. No abstract available.

28.

Cancer incidence in Khartoum, Sudan: first results from the Cancer Registry, 2009-2010.

Saeed IE, Weng HY, Mohamed KH, Mohammed SI.

Cancer Med. 2014 Aug;3(4):1075-84. doi: 10.1002/cam4.254. Epub 2014 May 13.

29.

Breast-cancer screening with trained volunteers in a rural area of Sudan: a pilot study.

Abuidris DO, Elsheikh A, Ali M, Musa H, Elgaili E, Ahmed AO, Sulieman I, Mohammed SI.

Lancet Oncol. 2013 Apr;14(4):363-70. doi: 10.1016/S1470-2045(12)70583-1. Epub 2013 Jan 31.

PMID:
23375833
30.

Bolus intrathecal injection of ziconotide (Prialt®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study.

Mohammed SI, Eldabe S, Simpson KH, Brookes M, Madzinga G, Gulve A, Baranidharan G, Radford H, Crowther T, Buchser E, Perruchoud C, Batterham AM.

Neuromodulation. 2013 Nov-Dec;16(6):576-81; discussion 582. doi: 10.1111/ner.12003. Epub 2012 Dec 3.

PMID:
23205907
31.

The African Organization for Research and Training in Cancer: historical perspective.

Mohammed SI, Williams CK, Ndom P, Holland JF.

Curr Oncol. 2012 Oct;19(5):272-6. doi: 10.3747/co.19.1075.

32.

Role of epigenetics in cancer health disparities.

Mohammed SI, Springfield S, Das R.

Methods Mol Biol. 2012;863:395-410. doi: 10.1007/978-1-61779-612-8_25. Review.

PMID:
22359308
33.

Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors.

Bajaj G, Kim MR, Mohammed SI, Yeo Y.

J Control Release. 2012 Mar 28;158(3):386-92. doi: 10.1016/j.jconrel.2011.12.001. Epub 2011 Dec 9. Erratum in: J Control Release. 2012 Aug 20;162(1):257.

34.

Mammography and ultrasound imaging of preinvasive and invasive canine spontaneous mammary cancer and their similarities to human breast cancer.

Mohammed SI, Meloni GB, Pinna Parpaglia ML, Marras V, Burrai GP, Meloni F, Pirino S, Antuofermo E.

Cancer Prev Res (Phila). 2011 Nov;4(11):1790-8. doi: 10.1158/1940-6207.CAPR-11-0084. Epub 2011 Jul 29.

35.

Effect of a photoactivated rhodium complex in melanoma.

Kim MR, Morrison H, Mohammed SI.

Anticancer Drugs. 2011 Oct;22(9):896-904. doi: 10.1097/CAD.0b013e32834850a5.

PMID:
21642837
36.

Staff knowledge, adherence to infection control recommendations and seroconversion rates in hemodialysis centers in Khartoum.

Elamin S, Salih LO, Mohammed SI, Ali SE, Mohammed NF, Hassan EH, Ahmed MA, Rahamtalla AA, Abu-Aisha H.

Arab J Nephrol Transplant. 2011 Jan;4(1):13-9.

PMID:
21469590
37.

In pursuit of a prognostic marker in canine mammary tumors.

Miller MA, Mohammed SI.

Vet J. 2011 Sep;189(3):245. doi: 10.1016/j.tvjl.2010.12.005. Epub 2011 Jan 28. No abstract available.

PMID:
21277242
38.

Gender differences in gemcitabine (Gemzar) efficacy in cancer cells: effect of indole-3-carbinol.

Lyn-Cook BD, Mohammed SI, Davis C, Word B, Haefele A, Wang H, Hammons G.

Anticancer Res. 2010 Dec;30(12):4907-13.

PMID:
21187469
39.

Breast cancer burden in central Sudan.

Elgaili EM, Abuidris DO, Rahman M, Michalek AM, Mohammed SI.

Int J Womens Health. 2010 Aug 9;2:77-82.

40.

Effects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder.

Dhawan D, Craig BA, Cheng L, Snyder PW, Mohammed SI, Stewart JC, Zheng R, Loman RA, Foster RS, Knapp DW.

Mol Cancer Ther. 2010 May;9(5):1371-7. doi: 10.1158/1535-7163.MCT-10-0049. Epub 2010 Apr 27.

41.

Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions.

Burrai GP, Mohammed SI, Miller MA, Marras V, Pirino S, Addis MF, Uzzau S, Antuofermo E.

BMC Cancer. 2010 Apr 22;10:156. doi: 10.1186/1471-2407-10-156.

42.

Prevalence and classification of spontaneous mammary intraepithelial lesions in dogs without clinical mammary disease.

Mouser P, Miller MA, Antuofermo E, Badve SS, Mohammed SI.

Vet Pathol. 2010 Mar;47(2):275-84. doi: 10.1177/0300985809358603. Epub 2010 Jan 22.

PMID:
20106771
43.

Proteomics-based approach to elucidate the mechanism of antitumor effect of curcumin in cervical cancer.

Madden K, Flowers L, Salani R, Horowitz I, Logan S, Kowalski K, Xie J, Mohammed SI.

Prostaglandins Leukot Essent Fatty Acids. 2009 Jan;80(1):9-18. doi: 10.1016/j.plefa.2008.10.003. Epub 2008 Dec 5.

PMID:
19058955
44.

Proteomics and genomics of urinary bladder cancer.

Mohammed SI, Rahman M.

Proteomics Clin Appl. 2008 Sep;2(9):1194-207. doi: 10.1002/prca.200780089. Epub 2008 Jul 21.

PMID:
21136917
45.

Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach.

Perera CN, Spalding HS, Mohammed SI, Camarillo IG.

Exp Biol Med (Maywood). 2008 Jun;233(6):708-20. doi: 10.3181/0710-RM-281. Epub 2008 Apr 11.

PMID:
18408141
46.

Proteomic-based approach for biomarkers discovery in early detection of invasive urothelial carcinoma.

Li J, Abraham S, Cheng L, Witzmann FA, Koch M, Xie J, Rahman M, Mohammed SI.

Proteomics Clin Appl. 2008 Jan;2(1):78-89. doi: 10.1002/prca.200780027. Epub 2007 Dec 17.

PMID:
21136781
47.

Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer.

Antuofermo E, Miller MA, Pirino S, Xie J, Badve S, Mohammed SI.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2247-56. Epub 2007 Nov 2.

48.

Study of feline oral squamous cell carcinoma: potential target for cyclooxygenase inhibitor treatment.

DiBernardi L, Doré M, Davis JA, Owens JG, Mohammed SI, Guptill CF, Knapp DW.

Prostaglandins Leukot Essent Fatty Acids. 2007 Apr;76(4):245-50. Epub 2007 Mar 26.

PMID:
17383864
49.

Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects.

Mohammed SI, Dhawan D, Abraham S, Snyder PW, Waters DJ, Craig BA, Lu M, Wu L, Zheng R, Stewart J, Knapp DW.

Mol Cancer Ther. 2006 Feb;5(2):329-36.

50.

Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.

Abraham S, Knapp DW, Cheng L, Snyder PW, Mittal SK, Bangari DS, Kinch M, Wu L, Dhariwal J, Mohammed SI.

Clin Cancer Res. 2006 Jan 15;12(2):353-60.

Supplemental Content

Loading ...
Support Center